Corporate News – Qianjiang Yongan Pharmaceutical Co., Ltd.
Qianjiang Yongan Pharmaceutical Co., Ltd. (ticker 002365.SZ) completed a trading day on Friday, 23 November 2023, with its share price unchanged at CN¥ 11.27. The stock’s trading volume for the period ending at 10:32 PM Central Europe was CN¥ 106.5 million, a modest figure relative to the company’s current market capitalization of CN¥ 475.9 million and a total outstanding share supply of 294.7 million.
Market Performance Overview
- 24‑Hour Price Movement: Flat (0 % change)
- Current Price: CN¥ 11.27
- Total Volume Traded (last 24 h): CN¥ 106.5 million
- Market Capitalization: CN¥ 475.9 million
- Average Volume (last 200 days): CN¥ 12.71
- 52‑Week High: CN¥ 18.10 (14 November 2025)
- 52‑Week Low: CN¥ 9.82 (29 June 2026)
- Month‑End Performance: Down 19.22 % since the end of the previous month
The flat trading day reflects a period of consolidation as the market digests the latest corporate announcement. Analysts note that the share price has been under pressure, yet the valuation remains within a range that could attract long‑term investors who recognise the company’s niche in taurine production.
Recent Corporate Development
Qianjiang Yongan Pharmaceutical has issued a brief announcement regarding an ongoing acquisition of a financial product. Although the statement was concise and did not disclose specific operational or financial details, it signals continued strategic activity. The announcement was released through Yong’an Pharmaceutical, the company’s reporting partner, underscoring the importance of regulatory compliance and transparency in the Chinese market.
Comparative Performance of Related Stocks
| Ticker | Exchange | 24‑Hour Change | Current Price | Market Cap (CN¥) | P/E Ratio |
|---|---|---|---|---|---|
| 2291.HK | HKSE | –0.21 % | HKD 14.07 | HKD 615.7 mn | 20.25 |
| 002845.SZ | SZSE | 0 % | CN¥ 12.63 | CN¥ 566.4 mn | 57.14 |
| 605088.SS | SSE | 0 % | CN¥ 20.48 | CN¥ 567.3 mn | 15.92 |
| 02477.HK | HKSE | –17.19 % | HKD 0.11 | HKD 613.9 mn | – |
| 603610.SS | SSE | 0 % | CN¥ 11.24 | CN¥ 563.2 mn | 127.91 |
The relative stability of Qianjiang Yongan Pharmaceutical’s share price stands in contrast to the notable decline of Wellcell (02477.HK), which fell 17.19 % during the same period. The broader market, as reflected by the Hang Seng Index, experienced a general downward trend, especially within technology and consumer sectors. Nonetheless, the defensive stance of several stocks indicates that investor sentiment remains cautious but not entirely pessimistic.
Company Profile
Qianjiang Yongan Pharmaceutical Co., Ltd. is headquartered in Qianjiang, China. The firm specialises in the development, manufacturing, and marketing of taurine, offering both medical‑grade and food‑additive variants. Its products cater to a growing demand for health‑related supplements and nutritional additives. The company went public on the Shenzhen Stock Exchange on 5 March 2010 and has maintained a consistent presence in the specialty chemicals sector. More detailed information about its product portfolio and corporate strategy can be found on the company’s website: www.chinataurine.com .
